Urits Ivan, Smoots Daniel, Franscioni Henry, Patel Anjana, Fackler Nathan, Wiley Seth, Berger Amnon A, Kassem Hisham, Urman Richard D, Manchikanti Laxmaiah, Abd-Elsayed Alaa, Kaye Alan D, Viswanath Omar
Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Creighton University School of Medicine, Phoenix Regional Campus, Phoenix, AZ, USA.
Pain Ther. 2020 Jun;9(1):145-160. doi: 10.1007/s40122-020-00157-5. Epub 2020 Feb 27.
This is a comprehensive literature review of the available evidence and techniques of foot injections for chronic pain conditions. It briefly describes common foot chronic pain syndromes and then reviews available injection techniques for each of these syndromes, weighing the available evidence and comparing the available approaches.
Foot and ankle pain affects 20% of the population over 50 and significantly impairs mobility and ability to participate in activities of daily living (ADLs), as well as increases fall risk. It is commonly treated with costly surgery, at times with questionable efficacy. Injection therapy is challenging when the etiology is anatomical or compressive. Morton's neuroma is a budging of the interdigital nerve. Steroid, alcohol, and capsaicin injections provide some benefit, but it is short lived. Hyaluronic acid (HA) injection provided long-term relief and could prove to be a viable treatment option. Achilles tendinopathy (AT) is most likely secondary to repeat tendon stress-platelet-rich-plasma (PRP) and prolotherapy have been trialed for this condition, but more evidence is required to show efficacy. Similar injections were trials for plantar fasciitis and achieved only short-term relief; however, some evidence suggests that PRP injections reduce the frequency of required therapy. Tarsal tunnel syndrome, a compressive neuropathy carries a risk of permanent neural injury if left untreated. Injection therapy can provide a bridge to surgery; however, surgical decompression remains the definitive therapy. When the etiology is inflammatory, steroid injection is more likely to provide benefit. This has been shown in several studies for gout, as well as osteoarthritis of the foot and ankle and treatment-refractory rheumatoid arthritis. HA showed similar benefit, possibly due to anti-inflammatory effects. Stem cell injections may provide the additional benefit of structure restoration. Chronic foot pain is common in the general population and has significant associated morbidity and disability. Traditionally treated with surgery, these are costly and only somewhat effective. Injections provide an effective alternative financially and some evidence exists that they are effective in pain alleviation. However, current evidence is limited and the benefit described from injection therapy has been short-lived in most cases. Further studies in larger populations are required to evaluate the long-term effects of these treatments.
这是一篇关于足部注射治疗慢性疼痛病症的现有证据和技术的全面文献综述。它简要描述了常见的足部慢性疼痛综合征,然后回顾了针对每种综合征的现有注射技术,权衡现有证据并比较现有方法。
足部和踝关节疼痛影响20%的50岁以上人群,严重损害活动能力和参与日常生活活动(ADL)的能力,并增加跌倒风险。通常采用代价高昂的手术治疗,有时疗效存疑。当病因是解剖学或压迫性时,注射治疗具有挑战性。 Morton神经瘤是指间神经的肿胀。类固醇、酒精和辣椒素注射有一定益处,但持续时间短。透明质酸(HA)注射可提供长期缓解,可能成为一种可行的治疗选择。跟腱病(AT)最可能继发于反复的肌腱应力,富含血小板血浆(PRP)和注射增殖疗法已针对这种情况进行试验,但需要更多证据来证明其疗效。类似的注射已用于足底筋膜炎试验,仅取得短期缓解;然而,一些证据表明PRP注射可减少所需治疗的频率。跗管综合征,一种压迫性神经病变,如果不治疗有永久性神经损伤的风险。注射治疗可为手术提供过渡;然而,手术减压仍是最终治疗方法。当病因是炎症性时,类固醇注射更可能有益。这在多项关于痛风、足部和踝关节骨关节炎以及治疗难治性类风湿关节炎的研究中得到证实。HA显示出类似的益处,可能归因于抗炎作用。干细胞注射可能提供结构恢复的额外益处。慢性足部疼痛在普通人群中很常见,且伴有显著的相关发病率和残疾。传统上采用手术治疗,费用高昂且效果有限。注射提供了一种经济有效的替代方法,并且有一些证据表明它们在缓解疼痛方面有效。然而,目前的证据有限,并且在大多数情况下,注射治疗所描述的益处是短暂的。需要在更大规模人群中进行进一步研究以评估这些治疗的长期效果。